Clinical Trials Logo

Clinical Trial Summary

This randomized clinical trial was conducted to examine and compare the effectiveness of pulpotomy in primary molars treated with calcium silicate based materials including Biodentine and two different mineral trioxide aggregate (MTA) products (white ProRoot® MTA and MTA Plus®). Ferric sulfate pulpotomy was selected to represent the control group. 116 primary molars in 29 children were treated by pulpotomy and followed for a period of 24 months.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Extensive Decay in Primary Molars

NCT number NCT03135626
Study type Interventional
Source Istanbul University
Contact
Status Completed
Phase Phase 3
Start date March 15, 2013
Completion date February 15, 2016

See also
  Status Clinical Trial Phase
Completed NCT01733420 - Biodentine Versus White MTA Pulpotomy Phase 3